Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 12;6(4):e87.
doi: 10.2196/mhealth.9187.

Interactive Two-Way mHealth Interventions for Improving Medication Adherence: An Evaluation Using The Behaviour Change Wheel Framework

Affiliations

Interactive Two-Way mHealth Interventions for Improving Medication Adherence: An Evaluation Using The Behaviour Change Wheel Framework

Nicole Chiang et al. JMIR Mhealth Uhealth. .

Abstract

Background: Medication adherence is an important but highly complex set of behaviors, which for life-threatening and infectious diseases such as HIV carry critical consequences for individual and public health. There is growing evidence that mobile phone text messaging interventions (mHealth) connecting providers with patients positively impact medication adherence, particularly two-way engagement platforms that require bidirectional communication versus one-way in which responses are not mandatory. However, mechanisms of action have not been well defined. The Behavior Change Wheel is a comprehensive framework for behavior change that includes an all-encompassing model of behavior known as Capability Opportunity Motivation-Behavior and is complemented by a taxonomy of behavior change techniques. Evaluating mHealth interventions for medication adherence using these tools could provide useful insights that may contribute to optimizing their integration into the healthcare system and successful scaling-up.

Objective: This study aimed to help address the current knowledge gap regarding how two-way mHealth interventions for medication adherence may work by applying the Behavior Change Wheel to characterize WelTel: an interactive digital health outreach platform with robust evidence for improving adherence to antiretroviral therapy.

Methods: To characterize how WelTel may promote medication adherence, we applied the Behavior Change Wheel to systematically (1) generate a behavioral diagnosis through mapping known antiretroviral therapy adherence barriers onto the Capability Opportunity Motivation-Behavior model of behavior, (2) specify the behavior change techniques that WelTel delivers, (3) link identified behavior change techniques to corresponding intervention functions of the Behavior Change Wheel, and (4) connect these behavior change techniques and intervention functions to respective Capability Opportunity Motivation-Behavior influences on behavior to determine potential mechanisms of action.

Results: Our evaluation of WelTel using the Behavior Change Wheel suggests that most of its impact is delivered primarily through its personalized communication component, in which 8 different behavior change techniques were identified and linked with 5 intervention functions (environmental restructuring, enablement, education, persuasion, and training). Its mechanisms of action in promoting antiretroviral therapy adherence may involve addressing all Capability Opportunity Motivation-Behavior influences on behavior (physical and psychological capability, physical and social opportunity, reflective and automatic motivation).

Conclusions: Systematically unpacking the potential active ingredients of effective interventions facilitates the creation and implementation of more parsimonious, tailored, and targeted approaches. Evaluating WelTel using the Behavior Change Wheel has provided valuable insights into how and why such interactive two-way mHealth interventions may produce greater impact than one-way in addressing both nonintentional and intentional forms of nonadherence. The application of the Behavior Change Wheel for evidence synthesis across mHealth interventions targeting various conditions would contribute to strengthening the knowledge base regarding how they may work to impact medication adherence behavior.

Keywords: chronic disease; disease management; mHealth; medication adherence; primary health care.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: RTL has founded WelTel International mHealth Society (a nonprofit organization) and WelTel Inc (a company) to help develop and scale the technologies to deliver the research-based services and has an interest in both organizations.

Figures

Figure 1
Figure 1
Behavior Change Wheel (image spelling has been modified, based on Michie S et al [18]).
Figure 2
Figure 2
Capability Opportunity Motivation - Behavior (COM-B) model of behavior (image spelling has been modified, based on Michie S et al [18]).
Figure 3
Figure 3
Determining potential mechanisms of action of an intervention using the Behavior Change Wheel (BCW).

Similar articles

Cited by

References

    1. World Health Organization . Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva, Switzerland: WHO; 2013. - PubMed
    1. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, Wilson K, Buchan I, Gill CJ, Cooper C. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006 Nov;3(11):e438. doi: 10.1371/journal.pmed.0030438. http://dx.plos.org/10.1371/journal.pmed.0030438 05-PLME-RA-0713R3 - DOI - DOI - PMC - PubMed
    1. Bärnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell ML. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis. 2011 Dec;11(12):942–51. doi: 10.1016/S1473-3099(11)70181-5. http://europepmc.org/abstract/MED/22030332 S1473-3099(11)70181-5 - DOI - PMC - PubMed
    1. Mannheimer S, Hirsch-Moverman Y. What we know and what we do not know about factors associated with and interventions to promote antiretroviral adherence. Curr Infect Dis Rep. 2015 Apr;17(4):466. doi: 10.1007/s11908-015-0466-9. - DOI - PubMed
    1. Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 - An ambitious treatment target to help end the AIDS epidemic. Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2014. http://www.unaids.org/sites/default/files/media_asset/90-90-90_en_0.pdf .

LinkOut - more resources